False‐negative programmed death‐ligand 1 immunostaining in ethanol‐fixed endobronchial ultrasound‐guided transbronchial needle aspiration specimens of non‐small‐cell lung cancer patients

AIMS: Programmed death‐ligand 1 (PD‐L1) immunostaining is used to predict which non‐small‐cell lung cancer (NSCLC) patients will respond best to treatment with programmed cell death protein 1/PD‐L1 inhibitors. PD‐L1 immunostaining is sometimes performed on alcohol‐fixed cytological specimens instead...

Descripción completa

Detalles Bibliográficos
Autores principales: Koomen, Bregje M, Vreuls, Willem, de Boer, Mirthe, de Ruiter, Emma J, Hoelters, Juergen, Vink, Aryan, Willems, Stefan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519150/
https://www.ncbi.nlm.nih.gov/pubmed/33772818
http://dx.doi.org/10.1111/his.14373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519150/
https://www.ncbi.nlm.nih.gov/pubmed/33772818
http://dx.doi.org/10.1111/his.14373

Ejemplares similares